Home › NCT07043101

Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation

Feasibility and Effectiveness of Goal Driven Extended Reality for Lower Limb Rehabilitation: A Pilot Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Inpatient at Sunnyview Rehabilitation Hospital
* Receiving or scheduled to receive Vector-based gait training therapy
* At least 18 years of age at the time of enrollment Exclusion Criteria
* Unable to use the Vector due to contraindications for Vector use (\>500 lb or \<30 lb), external halo neck support, severe osteoporosis, uncontrolled diabetes, uncontrolled hypertension, unstable fractures)
* Unable to follow 2 step commands
* Vertigo or vision abnormalities contraindicated for MR use
* Unable to ambulate prior to current injury
* In the judgment of the clinician, is not a good fit for the study

About the study

This pilot study will evaluate the feasibility and preliminary effectiveness of incorporating Extended Reality (XR) into the treatment of patients undergoing Lower Limb Rehabilitation (LLR) using the Vector Gait and Safety System. LLR requires repetitive motions over the span of weeks or months with the aim of restoring mobility. This duration of time poses challenges with motivation and increases the burden on the physical therapists. The use of XR in conjunction with conventional physical therapy could significantly increase motivation, along with providing therapists with new ways of tracking the patient's recovery. Pilot study results will be used to propose new and innovative approaches to physical recovery during inpatient rehabilitation, potentially increasing motivation, enhancing therapy participation, and reducing the overall time taken for recovery.

What is being tested

• Extended Reality based Gait Rehabilitation (other)

Sponsor: University at Albany · Participants: 24 · Started: May 12, 2025

Contact the study team

• Jeremy Varghese · Phone: 3124204491
• Amy Teale · Phone: 518-386-3613

Official record on ClinicalTrials.gov — NCT07043101

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.